Clinical Pilot and Feasibility Award Grant

Clinical Pilot and Feasibility Award Grant

Status: ACTIVE
Funder: Cystic Fibrosis Foundation
Amount: Up to US $80,000
Last Updated: February 20, 2026

Summary

The Clinical Pilot and Feasibility Award from the Cystic Fibrosis Foundation supports innovative research involving human subjects aimed at developing new hypotheses and methods pertinent to cystic fibrosis. With funding up to $150,000 per year, the award encourages promising new investigators to gather preliminary data essential for larger-scale studies. Special consideration is given to projects tackling underresearched topics or creative solutions to CF challenges, fostering advancements in care and treatment for individuals with cystic fibrosis.

Overview

About the Cystic Fibrosis Foundation The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care. To achieve this mission, various types of grants and awards are offered to support meritorious research in CF. Clinical Pilot and Feasibility Award Award Overview Clinical Pilot and Feasibility Awards are offered to support projects involving human subjects (see 45 CFR§46.102(f)) that will develop and test new hypotheses and/or new methods (or those being applied to the problems of cystic fibrosis for the first time), and to support promising new investigators as they establish themselves in research areas relevant to cystic fibrosis. The intent of these awards is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger-scale research and/or multi-center, collaborative trial. Special consideration will be given to those projects that pursue new approaches, study underresearched topics, or investigate more creative avenues of research to address the problems of CF. Applications for continued funding of existing projects, or for long-term support of an investigator, will not be considered. Note that preliminary data is not required; however, applicants must provide sufficient background information and rationale to support moving this work into human subjects’ research. Funding Amount Applicants may request funding of up to $80,000 per year, plus an additional twelve (12) percent indirect costs for single-center clinical studies; and up to $150,000 per year, plus twelve (12) percent indirect costs for multi-center clinical studies. Up to an additional $50,000 may be available via supplemental funding to address High Priority Areas.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.